Robert Lorne Hopfner bought $17k of EVMN
director, owner at Evommune, Inc.. 1,000 shares at an average of $17.35, traded Dec 19, 2025, filed Dec 22, 2025.
Score components
- +15RoleDirector
- 0Trade size$17k at market
- +6Relative to holdingsHoldings up 33%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001012975-25-000937, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 19, 2025 | POpen-market purchase Common Stockindirect: By Trust | +1,000 | $17.35 | $17k | 4,026 | Dec 22, 2025 |
Related signals
Other insiders at Evommune, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 60Notable | Evommune, Inc. | Ra Capital Management, L.p. director, owner | $20M 1,250,000 shares | +82% | |
| 53Moderate | Evommune, Inc. | LSP 7 Cooperative UA owner | $25M 1,562,500 shares | +46% | |
| 61Notable | Evommune, Inc. | Weegen Felice Isabel Verduyn-van director, owner | $25M 1,562,500 shares | +46% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.